Prelude Therapeutics Inc

PRLD

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001678660

SEC filings (opens in a new tab)

No open-market purchases or sales by Prelude Therapeutics Inc insiders were filed in the last 90 days; 75 institutions reported holding it in 13F filings for Q2 2026, worth $264.3M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Prelude Therapeutics Inc changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of PRLD: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Of which not filed for Q2 2026	Q2 2026	Change
Holders	55	1	75	+21
Shares	30.8M	573	49.6M	+18.8M (+61.2%)
Value	$105.2M	$1.96K	$264.3M	+$159.1M (+151.2%)

1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (34)

Institutions that held Prelude Therapeutics Inc at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to PRLD in Q2 2026
Institution	Shares	Value	% of portfolio
Ra Capital Management, L.P.	6,475,882	$34.5M	0.30%
Soleus Capital Management, L.P.	3,378,378	$18.0M	0.62%
Adage Capital Partners GP, L.L.C.	766,095	$4.08M	0.01%
Vanguard Portfolio Management LLC	193,920	$1.03M	0.00%
Hillsdale Investment Management Inc.	81,400	$433.9K	0.01%
Bank of New York Mellon Corp	68,187	$363.4K	0.00%
Charles Schwab Investment Management Inc	67,622	$360.4K	0.00%
Squarepoint Ops LLC	59,540	$317.3K	0.00%
Panagora Asset Management Inc	47,574	$253.6K	0.00%
Mariner, LLC	45,261	$241.2K	0.00%
Nuveen, LLC	37,023	$197.3K	0.00%
Invesco Ltd.	34,742	$185.2K	0.00%
State of Wyoming	32,862	$175.2K	0.02%
Deutsche Bank AG	27,824	$148.3K	0.00%
Wells Fargo & Company	25,325	$135.0K	0.00%
Price T Rowe Associates Inc	22,758	$122.0K	0.00%
Rhumbline Advisers	22,074	$117.6K	0.00%
ExodusPoint Capital Management, LP	15,475	$82.5K	0.00%
New York State Common Retirement Fund	14,200	$75.7K	0.00%
Mangrove Partners	13,352	$71.2K	0.00%
Mirae Asset Global ETFs Holdings Ltd.	12,784	$68.1K	0.00%
Gsa Capital Partners LLP	12,672	$68.0K	0.00%
Spark Investment Management LLC	10,600	$56.5K	0.11%
Police & Firemen's Retirement System of New Jersey	10,492	$55.9K	0.00%
Alliancebernstein L.P.	10,530	$36.0K	0.00%
Los Angeles Capital Management LLC	6,430	$34.3K	0.00%
STRS Ohio	5,500	$29.3K	0.00%
Legal & General Group Plc	2,699	$14.4K	0.00%
Ameritas Investment Partners, Inc.	2,520	$13.4K	0.00%
Tower Research Capital LLC (TRC)	2,377	$12.7K	0.00%
Russell Investments Group, Ltd.	2,220	$11.8K	0.00%
Quarry LP	755	$4.02K	0.00%
Sterling Capital Management LLC	97	$517	0.00%
Caitong International Asset Management Co., Ltd	18	$96	0.00%

Sold out (13)

Institutions that held Prelude Therapeutics Inc at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of PRLD in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
EcoR1 Capital, LLC	947,049	$3.24M
Susquehanna International Group, LLP	267,788	$915.8K
Jane Street Group, LLC	192,963	$659.9K
HRT Financial LP	58,699	$200.0K
XTX Topco Ltd	57,190	$195.6K
Colony Group, LLC	50,007	$171.0K
Omers Administration Corp	32,700	$111.8K
Prudential Financial Inc	17,420	$59.6K
Point72 Asset Management, L.P.	16,329	$55.8K
Diametric Capital, LP	11,980	$41.0K
Nine Masts Capital Ltd	11,699	$40.0K
American Century Companies Inc	10,294	$35.2K
Caldwell Sutter Capital, Inc.	1,000	$3.42K

Not filed for Q2 2026 yet (1)

Institutions that held Prelude Therapeutics Inc at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PRLD in Q1 2026 that haven't filed for Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
CWM, LLC	573	$1.96K